查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425533

2024 年止血剂全球市场报告

Hemostats Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，止血剂市场规模一直强劲成长。将从2023年的31.7亿美元扩大到2024年的34.6亿美元，复合年增长率为9.3%。业绩期间的成长归因于外科手术的进步、老年人口的不断增长、慢性病和凝血病的流行，以及心血管手术与整形外科应用的扩展。

2023年，北美是止血剂市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。止血剂市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球止血剂市场驱动因素与限制因素
    • 市场驱动力
    • 市场限制
  • 2018-2023年全球止血剂市场规模表现及成长
  • 2023-2028、2033年全球止血剂市场规模及成长预测

第六章市场区隔

  • 全球止血剂市场，按类型细分、实际和预测，2018-2023、2023-2028、2033
  • 基于凝血酶的止血剂
  • 氧化再生纤维素系止血剂
  • 组合止血器
  • 明胶止血剂
  • 胶原蛋白止血剂
  • 全球止血剂市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 主动止血剂
  • 被动止血剂
  • 组合止血器
  • 其他产品
  • 全球止血剂市场，依配方、性能及预测细分，2018-2023、2023-2028、2033
  • 基质和凝胶止血剂
  • 止血片和垫片
  • 海绵止血剂
  • 粉末止血剂
  • 全球止血剂市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 整形外科
  • 一般外科
  • 神经外科
  • 心血管外科
  • 重组手术
  • 妇科手术
  • 其他用途

第 7 章 区域与国家分析

  • 全球止血剂市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球止血剂市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 止血剂市场竞争形势
  • 止血剂市场公司概况
    • CR Bard Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Integra LifeSciences Corporation
    • Marine Polymer Technologies Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r12764

Hemostats Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats
  • 2) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
  • 3) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats
  • 4) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
  • Companies Mentioned: C. R. Bard Inc.; B. Braun Melsungen AG; Baxter International Inc.; Integra LifeSciences Corporation; Marine Polymer Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.17 billion in 2023 to $3.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to surgical advancements, a rising geriatric population, the prevalence of chronic diseases and coagulation disorders, and the expansion of cardiovascular surgeries with applications in orthopedics.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.77 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The projected growth in the forecast period can be attributed to factors such as emergency preparedness and pandemic response, the ongoing development of global healthcare infrastructure, a growing demand for minimally invasive surgeries, expanding applications in various medical specialties, and an increased focus on biocompatibility. Major trends expected in this period include ongoing product innovations, advancements in hemostatic technologies, and a continued emphasis on minimally invasive surgical approaches within the medical industry.

The hemostat market is witnessing substantial growth, primarily fueled by a notable increase in surgical procedures. Surgical interventions, encompassing invasive treatments for pathological conditions, rely heavily on hemostats to prevent excessive blood loss during operations. A report from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022 highlighted a significant surge in surgical and non-surgical procedures in 2021, with an average increase of 600 procedures compared to 2020. This surge underscores the growing demand for hemostats in various surgical settings, contributing to the overall expansion of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In July 2021, Baxter, a U.S.-based healthcare company, successfully acquired CryoLife, Inc for $60.8 million. This strategic move aims to further strengthen Baxter's PerClot portfolio, enhancing its capability to optimize patient care by addressing a broad spectrum of intraoperative bleeding. The acquisition positions Baxter to provide comprehensive solutions for both active and passive hemostasis, empowering surgeons to choose the most suitable product for specific bleeding scenarios. CryoLife, Inc., operating as a subsidiary of Artivion Inc., is a U.S.-based distributor specializing in cryogenically preserved human tissues, primarily for cardiac and vascular transplant applications.

Major companies operating in the hemostats market report are C. R. Bard Inc., B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Marine Polymer Technologies Inc., Pfizer Inc., Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, Dilon Technologies Inc., Mallinckrodt PLC, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Curasan AG, Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc., MC Squared Medical Inc., The Ohio Broach & Machine Co., and Unity Tool Inc.

North America was the largest region in the hemostats market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hemostats Market Characteristics

3. Hemostats Market Trends And Strategies

4. Hemostats Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hemostats Market Size and Growth

  • 5.1. Global Hemostats Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hemostats Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hemostats Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemostats Market Segmentation

  • 6.1. Global Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose-Based Hemostats
  • Combination Hemostats
  • Gelatin-Based Hemostats
  • Collagen-Based Hemostats
  • 6.2. Global Hemostats Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • Other Product
  • 6.3. Global Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Matrix And Gel Hemostats
  • Sheet And Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats
  • 6.4. Global Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Other Applications

7. Hemostats Market Regional And Country Analysis

  • 7.1. Global Hemostats Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hemostats Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemostats Market

  • 8.1. Asia-Pacific Hemostats Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemostats Market

  • 9.1. China Hemostats Market Overview
  • 9.2. China Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemostats Market

  • 10.1. India Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemostats Market

  • 11.1. Japan Hemostats Market Overview
  • 11.2. Japan Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemostats Market

  • 12.1. Australia Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemostats Market

  • 13.1. Indonesia Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemostats Market

  • 14.1. South Korea Hemostats Market Overview
  • 14.2. South Korea Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemostats Market

  • 15.1. Western Europe Hemostats Market Overview
  • 15.2. Western Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemostats Market

  • 16.1. UK Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemostats Market

  • 17.1. Germany Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemostats Market

  • 18.1. France Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemostats Market

  • 19.1. Italy Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemostats Market

  • 20.1. Spain Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemostats Market

  • 21.1. Eastern Europe Hemostats Market Overview
  • 21.2. Eastern Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemostats Market

  • 22.1. Russia Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemostats Market

  • 23.1. North America Hemostats Market Overview
  • 23.2. North America Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemostats Market

  • 24.1. USA Hemostats Market Overview
  • 24.2. USA Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemostats Market

  • 25.1. Canada Hemostats Market Overview
  • 25.2. Canada Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemostats Market

  • 26.1. South America Hemostats Market Overview
  • 26.2. South America Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemostats Market

  • 27.1. Brazil Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemostats Market

  • 28.1. Middle East Hemostats Market Overview
  • 28.2. Middle East Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemostats Market

  • 29.1. Africa Hemostats Market Overview
  • 29.2. Africa Hemostats Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hemostats Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemostats Market Competitive Landscape And Company Profiles

  • 30.1. Hemostats Market Competitive Landscape
  • 30.2. Hemostats Market Company Profiles
    • 30.2.1. C. R. Bard Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. B. Braun Melsungen AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Baxter International Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Integra LifeSciences Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Marine Polymer Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Hemostats Market Competitive Benchmarking

32. Global Hemostats Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hemostats Market

34. Hemostats Market Future Outlook and Potential Analysis

  • 34.1 Hemostats Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Hemostats Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Hemostats Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer